News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Neuren Pharmaceuticals Limited in First Phase 3 Trial in Australia


9/26/2007 1:16:07 PM

Sydney, Sep 26, 2007 (RWE via COMTEX) -- NURPF | charts | news | PowerRating -- (RWE Australian Business News) Neuren Pharmaceuticals (ASX:NEU) today announced that the first Australian patient had entered the Phase 3 clinical trial of its lead compound Glypromate, in development to reduce cognitive impairment after cardiac surgery.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES